Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Equol: pharmacokinetics and biological actions.

Setchell KD, Clerici C.

J Nutr. 2010 Jul;140(7):1363S-8S. doi: 10.3945/jn.109.119784. Epub 2010 Jun 2. Review.

2.

Equol: history, chemistry, and formation.

Setchell KD, Clerici C.

J Nutr. 2010 Jul;140(7):1355S-62S. doi: 10.3945/jn.109.119776. Epub 2010 Jun 2. Review.

3.

The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.

Setchell KD, Brown NM, Lydeking-Olsen E.

J Nutr. 2002 Dec;132(12):3577-84. Review.

4.

Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health.

Yuan JP, Wang JH, Liu X.

Mol Nutr Food Res. 2007 Jul;51(7):765-81. Review.

PMID:
17579894
5.

Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist.

Jackson RL, Greiwe JS, Schwen RJ.

Nutr Rev. 2011 Aug;69(8):432-48. doi: 10.1111/j.1753-4887.2011.00400.x. Review.

PMID:
21790611
6.

[Research development on relation between equol and soy foods health effect].

Liu B, Qin L, Wang P.

Wei Sheng Yan Jiu. 2010 Nov;39(6):784-6. Review. Chinese.

PMID:
21351654
7.

Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health.

Atkinson C, Frankenfeld CL, Lampe JW.

Exp Biol Med (Maywood). 2005 Mar;230(3):155-70. Review.

PMID:
15734719
8.

Prostate cancer chemoprevention by soy isoflavones: role of intestinal bacteria as the "second human genome".

Akaza H.

Cancer Sci. 2012 Jun;103(6):969-75. doi: 10.1111/j.1349-7006.2012.02257.x. Epub 2012 Apr 16. Review.

9.

Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insights.

Jackman KA, Woodman OL, Sobey CG.

Curr Med Chem. 2007;14(26):2824-30. Review.

PMID:
18045128
10.

Does equol production determine soy endocrine effects?

Shor D, Sathyapalan T, Atkin SL, Thatcher NJ.

Eur J Nutr. 2012 Jun;51(4):389-98. doi: 10.1007/s00394-012-0331-7. Epub 2012 Feb 25. Review.

PMID:
22366740
11.

Understanding the cardiovascular actions of soy isoflavones: potential novel targets for antihypertensive drug development.

Martin D, Song J, Mark C, Eyster K.

Cardiovasc Hematol Disord Drug Targets. 2008 Dec;8(4):297-312. Review.

PMID:
19202595
12.

[Equol: a metabolite of soy isoflavones by intestinal microflora--a review].

Zheng W, Hou Y, Yao W.

Wei Sheng Wu Xue Bao. 2013 Dec 4;53(12):1251-7. Review. Chinese.

PMID:
24697097
13.

Emerging research on equol and cancer.

Lampe JW.

J Nutr. 2010 Jul;140(7):1369S-72S. doi: 10.3945/jn.109.118323. Epub 2010 May 26. Review.

14.

O-desmethylangolensin: the importance of equol's lesser known cousin to human health.

Frankenfeld CL.

Adv Nutr. 2011 Jul;2(4):317-24. doi: 10.3945/an.111.000539. Epub 2011 Jun 28. Review.

16.

Soybean isoflavones in bone health.

Ishimi Y.

Forum Nutr. 2009;61:104-16. doi: 10.1159/000212743. Epub 2009 Apr 7. Review.

PMID:
19367115

Supplemental Content

Support Center